Celldex Therapeutics
Clinical trials sponsored by Celldex Therapeutics, explained in plain language.
-
New hope for chronic hives: Long-Term drug study launches
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of barzolvolimab for adults with chronic spontaneous urticaria (CSU), a condition causing frequent hives and itching. About 1,370 participants who finished earlier phase 3 trials will receive the drug and be monitored for…
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
New hope for cold hives and scratch-induced welts: phase 3 drug trial underway
Disease control Recruiting nowThis study tests an investigational drug called barzolvolimab in 240 adults who still get hives from cold temperatures or skin scratching despite taking antihistamines. Participants receive either the drug or a placebo to see if it can stop these reactions. The goal is to find a …
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 26, 2026 12:05 UTC